Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 6/20 | 0.59 |
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.53 |
| ▸ | ABCC1 | P33527 | 4/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.53 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | KCNH3 | Q9ULD8 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16391941 | 0.86 | ABCG2 (0.52) | TGFBR1ABCG2ABCC1ABCB1KMT2A | |
| SCHEMBL16391870 | 0.86 | ABCG2 (0.52) | TGFBR1ABCG2ABCC1ABCB1KMT2A | |
| SCHEMBL17812917 | 0.85 | TGFBR1 (0.57) | TGFBR1ABCG2ABCC1ABCB1MAPK14 | |
| SCHEMBL16391950 | 0.84 | TGFBR1 (0.47) | TGFBR1ABCG2ABCC1ABCB1CYP1A2 | |
| SCHEMBL21977577 | 0.84 | TGFBR1 (0.47) | TGFBR1ABCG2ABCC1ABCB1CYP1A2 | |
| SCHEMBL17812899 | 0.84 | CYP1A2 (0.52) | TGFBR1ABCG2ABCC1ABCB1MAPK14 | |
| SCHEMBL16391640 | 0.83 | CYP1A2 (0.63) | ABCG2ABCC1ABCB1MAPK14KMT2A | |
| SCHEMBL16391780 | 0.83 | IDH1 (0.61) | ABCG2ABCC1ABCB1KMT2ACYP1A2 | |
| SCHEMBL16392243 | 0.81 | ABCG2 (0.58) | ABCG2ABCC1ABCB1KMT2AKCNH3 | |
| SCHEMBL17812901 | 0.81 | TGFBR1 (0.46) | TGFBR1ABCG2ABCC1ABCB1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160158230-A1 | 2,4- OR 4,6-DIAMINOPYRIMIDINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER | SERVIER PHARMACEUTICALS LLC | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160158230-A1 | 2,4- OR 4,6-DIAMINOPYRIMIDINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER | IDH2, IDH3B, IDH3A | TGFBR1 3893/4885ABCG2 889/4885ABCC1 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.